1 / 32

Asthma Medication Administration Marcia Winston, MSN,CPNP,AE-C winstonm@email.chop

Asthma Medication Administration Marcia Winston, MSN,CPNP,AE-C winstonm@email.chop.edu The Children’s Hospital of Philadelphia Division of Pulmonary Medicine. Clinical Management of Asthma. NIH NHLBI NAEPP Expert Report 3 released in 2007 (1991, 1997, 2002).

vea
Download Presentation

Asthma Medication Administration Marcia Winston, MSN,CPNP,AE-C winstonm@email.chop

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Asthma Medication Administration Marcia Winston, MSN,CPNP,AE-C winstonm@email.chop.edu The Children’s Hospital of Philadelphia Division of Pulmonary Medicine

  2. Clinical Management of Asthma NIH NHLBI NAEPP Expert Report 3 released in 2007 (1991, 1997, 2002)

  3. Level of Severity-EPR-3 To be determined at time of Diagnosis to Initiate Treatment Classification of level severity is based on assessment of: • Number of days/week symptoms occur • Number of night awakenings/month • Interference with normal activity • Peak Flow (PEFR) or FEV1 (forced expiratory volume in 1 second) • Exacerbations requiring oral corticosteroids

  4. EPR-3 Classification of Asthma Severity Determines treatment Each age group (0-4 years of age, 5-11 years of age and 12-adult) Six steps Long-term control: preferred and alternative Step 1 Intermittent asthma Step 2-6 Persistent asthma

  5. EPR-3: Goals of Therapy: Control of Asthma • REDUCE IMPAIRMENT • Prevent chronic and troublesome symptoms (in the daytime, at night, or after exertion) • Maintain (near) normal pulmonary function • Maintain normal activity levels (including exercise) • Infrequent use of SABA </= twice a week NOT including pre-treatment of EIB • Satisfy and meet patient/families expectations

  6. EPR-3: Goals of Therapy: Control of Asthma • REDUCE RISK • Prevent recurrent: Exacerbations E.R. visits Hospitalizations • Prevent loss of lung function/for children prevent reduced lung growth • Provide optimal pharmacotherapy with minimal or no adverse effects of therapy

  7. Medications to Treat Asthma Two major categories of medications are: • Long-term control • Quick relief

  8. QVAR/beclomethasone dipropionate HFA40mcg, 80mcg/inhalation

  9. Pulmicort Flexhaler/budesonide90 mcg and 180 mcg/inhalation

  10. Pulmicort Respules/budesonide0.25mg/2ml, 0.5mg/2ml and 1mg/2ml nebulizer suspension

  11. Alvesco (ciclesonide) 80 mcg, 160 mcg/inhalation

  12. Flovent HFA/fluticasone propionate44mcg, 110mcg, 220mcg/inhalation

  13. Asmanex Twisthaler/mometasone furoate110mcg, 220mcg/inhalation

  14. Medications to Treat Asthma:Quick-Relief • Used in acute asthma episodes, relieve symptoms Generally they are short-acting beta2-agonists: albuterol (ProAir HFA, Proventil HFA, Ventolin HFA) levalbuterol pirbuterol ipratropium • Systemic corticosteroids

  15. Asthma: Under Control or Out of Control? Baylor Rule of Twos: • Take quick relief medicine > 2 times/week • Wake up at night due to asthma > 2 times/month • Refill quick relief inhaler prescription more than 2 times/year *one albuterol MDI=200 puffs/medicine=100 two puff doses*

  16. Medication Administration • Oral • Metered dose inhaler (MDI) and spacer • Dry powder inhaler(DPI) • Air Compressor/Nebulizer • Injection

  17. Asthma Devices:Medication Administration Metered dose inhalers (MDIs) w/CFC propellant have been discontinued Maxair (pirbuterol) will be off the market in 2013

  18. Asthma Devices:Medication Administration Metered dose inhalers (MDIs) w/ HFA (as of 2008) require maintenance: priming and rinsing

  19. Medication Administration • One way valve holding chambers

  20. Medication Administration Dry powder inhalers (DPI)

  21. Medication Administration • Nebulizer/air compressor

  22. Medication Administration • Nebulizer/air compressor

  23. InCheck Dial: Measures Inspiratory flow rate

  24. Medication Administration Air Compressor and Nebulizer: As per Rubin & Fink, “Aerosol Therapy for Children” • Home versus hospital: not the same • No published data supports the use of the blow-by technique • Aerosol deposition studies suggest that virtually no drug enters the airway • If not using a mouthpiece then the mask should be close fitting • If the mask is not close fitting or patient is crying aerosol deposition can also be affected Respiratory Care Clinics of North America 7:2 June 2001

  25. Asthma Out of Control*Frequent flyers*(symptoms, ER, hospital, over use of albuterol) • Assess and re-assess: • Observe patient’s medication administration technique, equipment and medications • Ask directly about adherence, “How often do you miss a dose of your long-term control medicine?” • Ask about the environment: pets and ETS. • Consider alternative diagnosis/comorbid conditions

  26. Managing Asthma:Sample Asthma Action Plan Describes what medicines to use and actions to take when well and when symptomatic/for attacks and emergency instructions National Heart, Lung, and Blood Institute

  27. Resources • Association of Asthma Educators-AAE: www.asthmaeducators.org • National Asthma Education and Prevention Program (EPR3 Guidelines) www.nhlbi.nih.gov/about/naepp/index.htm

More Related